Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Lee Jackson | Aug 18, 2015 at 8:22 AM EDT

4 Top Pharma Stocks That Should Outperform Out To 2016

ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for…

Jon C. Ogg | Aug 12, 2015 at 5:14 PM EDT

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

Bristol-Myers Squibb announced that the FDA has now extended the action date for the supplemental biologics license application for Opdivo…

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Chris Lange | Aug 6, 2015 at 2:20 PM EDT

5 Big FDA Decisions Expected in August

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

Chris Lange | Jul 23, 2015 at 10:55 AM EDT

Why Bristol-Myers Squibb Solid Earnings Beat Failed to Impress

Bristol-Myers Squibb released better-than-expected second-quarter financial results before the markets opened Thursday.

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

Chris Lange | Jun 26, 2015 at 11:35 AM EDT

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?

Chris Lange | Jun 25, 2015 at 8:10 AM EDT

Short Sellers Become More Focused on Big Pharma

The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Chris Lange | Jun 10, 2015 at 8:30 AM EDT

Short Sellers Back Off Big Pharma

The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Chris Lange | Jun 2, 2015 at 8:50 AM EDT

The 4 Overlooked Winners of ASCO

ThinkstockThe American Society of Clinical Oncology’s (ASCO) annual meeting is coming to a close. Companies and cancer drug developers across…

Chris Lange | May 28, 2015 at 9:30 AM EDT

Short Sellers More Selective on Big Pharma Stocks

The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short…

Chris Lange | May 12, 2015 at 9:50 AM EDT

Short Sellers Keep Strong Bets Against Big Pharma

The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Lee Jackson | May 8, 2015 at 9:20 AM EDT

4 Pharmaceutical Companies Leading the Breast Cancer Fight

In a new report, the RBC team focused on the companies that are making the most progress with treatments for…

1 … 24 25 26 27 28 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

4 Top Pharma Stocks That Should Outperform Out To 2016

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

Short Sellers Back Off Big Pharma

5 Big FDA Decisions Expected in August

Short Sellers Run For Cover From Major Pharma

Why Bristol-Myers Squibb Solid Earnings Beat Failed to Impress

Short Sellers Run for Cover in Big Pharma

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

The 4 Overlooked Winners of ASCO

Short Sellers More Selective on Big Pharma Stocks

Short Sellers Keep Strong Bets Against Big Pharma

4 Pharmaceutical Companies Leading the Breast Cancer Fight

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

4 Top Pharma Stocks That Should Outperform Out To 2016

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

Short Sellers Back Off Big Pharma

5 Big FDA Decisions Expected in August

Short Sellers Run For Cover From Major Pharma

Why Bristol-Myers Squibb Solid Earnings Beat Failed to Impress

Short Sellers Run for Cover in Big Pharma

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

The 4 Overlooked Winners of ASCO

Short Sellers More Selective on Big Pharma Stocks

Short Sellers Keep Strong Bets Against Big Pharma

4 Pharmaceutical Companies Leading the Breast Cancer Fight

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do